Primary thoracic wall tuberculosis: A rare case
Dear Editor, Musculoskeletal tuberculosis accounts for 1-2% of overall tuberculosis cases, of which 1-5% presents with thoracic wall involvement, a rare entity. [1] We report a case of primary thoracic wall tuberculosis in a 37-year-old female, presented with 3-month history of gradually enlarging lump in upper and outer quadrant of right breast. It was painless initially and became painful after 2 months. There was no history of tuberculosis. Local examination revealed deep-seated mass which was tender, soft in consistency, fl uctuant, fi xed, with overlying skin appearing normal. Draining axillary lymph nodes were not involved. Patient was HIV negative. Chest roentgenogram was normal. A high-frequency ultrasound demonstrated heterogeneously hyperechoic collection in anterior chest wall below the pectoralis muscle and over ribs of size 5.2 × 2 × 2.6 cms with few liquefi ed areas. Fine needle aspiration cytology revealed predominantly granular necrotic debris, large number of neutrophils and macrophages [ Figure 1 ].
Ziehl-Neelsen (ZN) staining was negative. Mycobacterium tuberculosis was detected in specimen of the aspirated abscess with real time polymerase chain reaction using COBAS ® TaqMan ® MTB Test. Growth was obtained on
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Lowenstein-Jensen medium after 42 days. On MPT64 immunochromatographic card test, growth was identifi ed as M. tuberculosis complex. Detailed examination ruled out any primary focus in the body. Directly observed treatment short course (DOTS) was started [2] and patient has shown improvement with complete regression of the thoracic mass.
Atypical presentation, paucibacillary nature and negative AFB smear makes the diagnosis diffi cult and time consuming, thereby, delaying the initiation of treatment leading to complications and mortality in a treatable disease. [3] This case emphasises that tuberculosis should be kept in mind as differential diagnosis when a case present with isolated thoracic wall abscess, in immunocompetent persons in endemic areas. 
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Vancomycin-resistant enterococcus (VRE) vs Methicillin-resistant Staphylococcus Aureus (MRSA)
Dear Editor, Antimicrobial resistance is a major concern in a clinical set-up. Newer pathogens are emerging day by day which pose a major threat in treating hospitalised patients. This correspondence highlights the bacteria which so far considered as a commensal has reached the status of highly virulent pathogen. The vancomycin-resistant enterococcus (VRE) is attaining virulence as Methicillin-resistant Staphylococcus aureus (MRSA). The incidence is more compared to MRSA. The key message is to highlight the importance of VRE strains that is increasingly seen in wound infections. Enterococcus was normally ignored by many clinicians in clinical samples as it is normal fl ora. But now it stands individually in most of the recurrent infections and interferes with the healing of wound. The source is always noted to be the faecal fl ora.
The recent studies show that VRE is emerging as a major threat in postoperative sepsis, which delays the process of wound healing. It is of utmost concern because it is a part of the normal fl ora in our body and in most sepsis, its occurrence is from an endogenous source only. This is evident in cases which show recurrence of sepsis with the bacterial strains with almost same sensitivity patterns. A comparison of the incidence rates of VRE and MRSA were analysed based on four categories from previous studies and the results were attained. Based on percentage of resistant strains isolated in the study by National Nosocomial Infections 
